Jury Rules Johnson & Johnson Responsible for Cancer in Recent Talc Case

A jury in Pennsylvania state court awarded $250,000 to the family of a woman who alleged that Johnson & Johnson’s talc-based baby powder caused her ovarian cancer. This verdict was delivered on Friday in the Philadelphia Court of Common Pleas.

The jury sided with the family of Gayle Emerson, who claimed that Johnson & Johnson had been aware of the dangers associated with its talc-based products for years but failed to adequately warn consumers about the risks.

The jury awarded Emerson’s family $50,000 in compensatory damages and $200,000 in punitive damages.

In response, Erik Haas, J&J’s worldwide vice president of litigation, stated that the company intends to appeal the decision.

“This token verdict reflects the jury’s appreciation that the claims were meritless and divorced from the science,” Haas remarked.

Leigh O’Dell, representing Emerson’s family from the Beasley Allen Law Firm, expressed that the jury found J&J’s product and corporate conduct directly responsible for Emerson’s death.

“While the jury’s award is less than we hoped, and significantly less than the amount necessary to punish J&J for their outrageous conduct, we are moving forward,” O’Dell added.

Emerson, a resident of Pennsylvania, initiated her lawsuit in 2019 but passed away six months later at the age of 68. Following her death from metastatic ovarian cancer, her son and daughter took over as plaintiffs in the case.

According to court records, Emerson used J&J’s baby powder from 1969 until 2017, when she learned from a relative about its association with an increased risk of ovarian cancer. She had been diagnosed with the disease two years prior to her death.

Currently, Johnson & Johnson faces lawsuits from over 67,000 plaintiffs in federal and state courts, all alleging that its talc-based products contained asbestos and caused various cancers, including ovarian cancer.

The company maintains that its products are safe, free from asbestos, and do not cause cancer. In 2020, J&J ceased the sale of talc-based baby powder in the U.S., opting instead for a cornstarch-based alternative.

Efforts by J&J to resolve ongoing litigation through bankruptcy have been rejected three times by federal courts, with the most recent rejection occurring in April of last year. These bankruptcy attempts had temporarily halted most ovarian cancer cases.

The first ovarian cancer case to proceed to trial after the bankruptcy-related pause resulted in a California jury awarding $40 million to two women in December.

Several cases are scheduled for trial in state courts in the upcoming months. While there has yet to be a trial in federal court, where most claims are consolidated, a recent ruling by a U.S. federal magistrate judge allows plaintiffs to present expert testimony linking baby powder use to ovarian cancer. J&J has indicated plans to appeal this ruling.

Product liability lawsuits, such as those against J&J, often rely on expert testimony to establish that the product in question can cause the alleged harm.

Prior to the bankruptcy attempts, J&J had a mixed record in talc trials, with verdicts reaching as high as $4.69 billion. The company has won some trials outright and had other verdicts reduced on appeal.

The majority of lawsuits focus on ovarian cancer claims, while a smaller portion involves allegations that talc caused mesothelioma, a rare and deadly cancer. Although J&J has settled some of these claims, no nationwide settlement has been reached, leading many mesothelioma lawsuits to proceed to trial in state courts in recent months.

A jury in Pennsylvania state court awarded $250,000 to the family of a woman who alleged that Johnson & Johnson’s talc-based baby powder caused her ovarian cancer. This verdict was delivered on Friday in the Philadelphia Court of Common Pleas.

The jury sided with the family of Gayle Emerson, who claimed that Johnson & Johnson had been aware of the dangers associated with its talc-based products for years but failed to adequately warn consumers about the risks.

The jury awarded Emerson’s family $50,000 in compensatory damages and $200,000 in punitive damages.

In response, Erik Haas, J&J’s worldwide vice president of litigation, stated that the company intends to appeal the decision.

“This token verdict reflects the jury’s appreciation that the claims were meritless and divorced from the science,” Haas remarked.

Leigh O’Dell, representing Emerson’s family from the Beasley Allen Law Firm, expressed that the jury found J&J’s product and corporate conduct directly responsible for Emerson’s death.

“While the jury’s award is less than we hoped, and significantly less than the amount necessary to punish J&J for their outrageous conduct, we are moving forward,” O’Dell added.

Emerson, a resident of Pennsylvania, initiated her lawsuit in 2019 but passed away six months later at the age of 68. Following her death from metastatic ovarian cancer, her son and daughter took over as plaintiffs in the case.

According to court records, Emerson used J&J’s baby powder from 1969 until 2017, when she learned from a relative about its association with an increased risk of ovarian cancer. She had been diagnosed with the disease two years prior to her death.

Currently, Johnson & Johnson faces lawsuits from over 67,000 plaintiffs in federal and state courts, all alleging that its talc-based products contained asbestos and caused various cancers, including ovarian cancer.

The company maintains that its products are safe, free from asbestos, and do not cause cancer. In 2020, J&J ceased the sale of talc-based baby powder in the U.S., opting instead for a cornstarch-based alternative.

Efforts by J&J to resolve ongoing litigation through bankruptcy have been rejected three times by federal courts, with the most recent rejection occurring in April of last year. These bankruptcy attempts had temporarily halted most ovarian cancer cases.

The first ovarian cancer case to proceed to trial after the bankruptcy-related pause resulted in a California jury awarding $40 million to two women in December.

Several cases are scheduled for trial in state courts in the upcoming months. While there has yet to be a trial in federal court, where most claims are consolidated, a recent ruling by a U.S. federal magistrate judge allows plaintiffs to present expert testimony linking baby powder use to ovarian cancer. J&J has indicated plans to appeal this ruling.

Product liability lawsuits, such as those against J&J, often rely on expert testimony to establish that the product in question can cause the alleged harm.

Prior to the bankruptcy attempts, J&J had a mixed record in talc trials, with verdicts reaching as high as $4.69 billion. The company has won some trials outright and had other verdicts reduced on appeal.

The majority of lawsuits focus on ovarian cancer claims, while a smaller portion involves allegations that talc caused mesothelioma, a rare and deadly cancer. Although J&J has settled some of these claims, no nationwide settlement has been reached, leading many mesothelioma lawsuits to proceed to trial in state courts in recent months.